Varaico: Literature-Extracted Genetic Variants

Gene:ANXA11
Variant:p.D40Y
Back to variants list

ANXA11

NM_145868.2:p.D40Y

Associated Papers

Genetic Spectrum and Phenotypic Variability in Chinese Patients with Multisystem Proteinopathy and Related Disorders.

Xia X et al.

Degenerative Neurological and Neuromuscular Disease, 2026

ANXA11 Variant-Associated Adult-Onset Myopathy: A Novel Phenotype.

Mahale RR et al.

Annals of Indian Academy of Neurology, 2025

Genetic architecture of amyotrophic lateral sclerosis: a comprehensive review.

Yuan L et al.

Journal of Genetics and Genomics = Yi Chuan Xue Bao, 2025

The novel missense variant D40V causes a young adult presentation of ANXA11-related myopathy.

Martins AP et al.

Neuromuscular Disorders : Nmd, 2025

ANXA11 Mutations in the FTD Spectrum: A Novel Finding in a Patient With Semantic Variant Primary Progressive Aphasia.

Meng Y et al.

European Journal of Neurology, 2025

Semantic variant primary progressive aphasia with ANXA11 p.D40G.

Lee SM et al.

Alzheimer's & Dementia : the Journal of the Alzheimer's Association, 2025

Annexin A11 mutations are associated with nuclear envelope dysfunction in vivo and in human tissues.

Marchica V et al.

Brain : a Journal of Neurology, 2025

A systematic review and functional in-silico analysis of genes and variants associated with amyotrophic lateral sclerosis.

Arreola-Aldape CA et al.

Frontiers in Neuroscience, 2025

40589786 (PubMed )
Supplement: Table_4.xlsx › ClinVar_filtered_variants

Human TDP43 is required for ALS‑related annexin A11 toxicity in Drosophila.

Barnard J et al.

Biomedical Reports, 2024

Dominantly inherited muscle disorders: understanding their complexity and exploring therapeutic approaches.

Findlay AR

Disease Models & Mechanisms, 2024

Genetic and in silico analysis of Indian sporadic young onset patient with amyotrophic lateral sclerosis.

Roychowdhury S et al.

Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration, 2024

Harnessing deep learning into hidden mutations of neurological disorders for therapeutic challenges.

Yang S et al.

Archives of Pharmacal Research, 2023

Common pathophysiology for ANXA11 disorders caused by aspartate 40 variants.

Natera-de Benito D et al.

Annals of Clinical and Translational Neurology, 2023

An atypical ALS with PSP-like symptoms caused by ANXA11 p.D40G mutation: A case report and literature review.

Zhang X et al.

Frontiers in Neurology, 2023

Semantic variant primary progressive aphasia with a pathogenic variant p.Asp40Gly in the ANXA11 gene.

Kim EJ et al.

European Journal of Neurology, 2022

Adult-onset dominant muscular dystrophy in Greek families caused by Annexin A11.

Johari M et al.

Annals of Clinical and Translational Neurology, 2022

ANXA11 mutations are associated with amyotrophic lateral sclerosis-frontotemporal dementia.

Wang Y et al.

Frontiers in Neurology, 2022

Clinical and genetic characteristics of amyotrophic lateral sclerosis patients with ANXA11 variants.

Sung W et al.

Brain Communications, 2022

A Novel Multisystem Proteinopathy Caused by a Missense ANXA11 Variant.

Leoni TB et al.

Annals of Neurology, 2021

A novel splicing variant of ANXA11 in a patient with amyotrophic lateral sclerosis: histologic and biochemical features.

Sainouchi M et al.

Acta Neuropathologica Communications, 2021

Genetic epidemiology of familial ALS in Brazil.

Nunes Gonçalves JP et al.

Neurobiology of Aging, 2021

Genetic screening of ANXA11 revealed novel mutations linked to amyotrophic lateral sclerosis.

Teyssou E et al.

Neurobiology of Aging, 2021

Unraveling the multifaceted insights into amyotrophic lateral sclerosis: Genetic underpinnings, pathogenesis, and therapeutic horizons.

Sharma R et al.

Mutation Research. Reviews in Mutation Research, 0

Select a paper to view details
UCSC Genome Browser·Imprint·Privacy·Terms·Feedback·Email Updates·

Regarding the variants extracted from papers and shown text snippets from research papers, the following holds: "Some rights reserved. This work permits non-commercial use, distribution and reproduction in any medium, provided the original author and source are credited."